KdT Ventures is launching a new biotechnology startup based on a drug it’s licensing from NGM Biopharmaceuticals, the companies announced Thursday. The deal hands the Austin-based venture firm’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results